Koppikar Utpal
- SEC CIK
- 0001742696
No open-market purchases or sales filed in the past year.
Current role at each company
- CCCC C4 Therapeutics, Inc.Directoras of Jun 26, 2026
- ATRA Atara Biotherapeutics, Inc.Chief Financial Officeras of Mar 6, 2023
- FLXN Flexion Therapeutics IncDirectoras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Koppikar Utpal as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATRA Atara Biotherapeutics, Inc.
Chief Financial Officer10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2023 (view filing) | Mar 2 | 4 days | Koppikar UtpalChief Financial Officer | SSale | −6.87K | $3.63 | −$24.9K | −3.6%182.0K after | |
| Feb 9, 2023 (view filing) | Feb 7 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −2.48K | $5.46 | −$13.6K | −1.3%188.8K after | |
| Nov 18, 2022 (view filing) | Nov 16 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −6.25K | $4.49 | −$28.1K | −3.2%191.3K after | 2 lots |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −5.94K | $5.04 | −$29.9K | −2.9%197.6K after | |
| Jun 10, 2022 (view filing) | Jun 8 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −5.85K | $5.63 | −$33.0K | −2.8%203.5K after | |
| May 19, 2022 (view filing) | May 17 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −5.58K | $5.32 | −$29.7K | −2.6%207.6K after | 2 lots |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −3.76K | $9.86 | −$37.1K | −1.7%213.2K after | 2 lots |
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −2.50K | $14.46 | −$36.1K | −1.6%155.7K after | |
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −3.65K | $17.12 | −$62.6K | −2.3%157.7K after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Koppikar UtpalChief Financial Officer | SSale | −3.58K | $12.53 | −$44.8K | −2.2%161.4K after |
CCCC C4 Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2023 (view filing) | Feb 8 | 2 days | Koppikar UtpalDirector | PPurchase | +5.67K | $5.60 | +$31.7K | New position5.67K after |